Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland
Enhancing tuberculosis case notifications through mapping sales of medicine in the private sector: a quasi-experimental study in Punjab province, Pakistan
Beatrice Kirubi, Kinz Ul Eman, Usman R. Lodhi, Razia K. Fatima, Ghulam Nabi Kazi, Tahmeena Tahmeena, Syed Karam Shah and Jacob Creswell
ITB document ITB-Iplus/GDF-MED/2024/3
Annex L. TB medicines target prices ITB-Iplus/GDF-MED/2024/3
Annex K. Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2024/3
Annex J. Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2024/3
Annex I. GMSD address list ITB-Iplus/GDF-MED/2024/3
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2024/3
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2024/3
Annex F. CDP Technical Tender Submission - Instructions for use ITB-Iplus/GDF-MED/2024/3
Annex E. Declaration of supply restrictions to countries ITB-Iplus/GDF-MED/2024/3
Pagination
- Previous page
- Page 4
- Next page